PS# [001]

Related by string. PS# [005] . PS# [002] . PS# [004] . PS# [003] * * Minardi Cosworth PS# . Dell EqualLogic PS# . PS# Pharmacopeia ability . Getac PS# . Plustek SmartOffice PS# . develop PS# . PS# Chorus . EqualLogic PS# . SmartOffice PS# . EqualLogic PS# storage . PS# DARA . Minardi PS# . PS# chassis *

Related by context. Frequent words. (Click for all words.) 72 ISIS # 69 INCB# [002] 69 CRx 68 HGS ETR1 68 RDEA# 68 BAY #-# 68 CA4P 67 Perifosine 67 Phase 2a trial 67 HspE7 67 PRX # 66 Zerenex 66 PF # [001] 65 AEZS 65 elesclomol 65 NGX# 65 ALN VSP 65 MGCD# [001] 65 RG# [001] 65 Phase IIa trial 65 PMX # 65 CoFactor 64 Phase 2b study 64 Phase 2a clinical 64 CUDC 64 Phase 2a 64 eltrombopag 64 Phase 2b 64 pharmacodynamic 64 Phase 1b 64 preclinical studies 64 Azixa 64 AZD# 63 MDV# 63 CYT# 63 LymphoStat B 63 Phase Ib 63 ALTU 63 mipomersen 63 Debio 63 investigational compound 63 Marqibo 63 SPP# [001] 63 talactoferrin 63 GRN#L 62 Locteron 62 Phase 2b trial 62 TREANDA 62 ZYBRESTAT 62 pralatrexate 62 Phase 2b clinical 62 MB# [004] 62 hematological malignancies 62 Phase IIa clinical 62 ALKS 62 CORLUX 62 ISENTRESS 62 CK # 62 pivotal Phase III 62 voreloxin 62 APD# 62 LEVADEX 61 Phase IIb clinical 61 AP# [003] 61 NKTR 61 ARRY 61 belinostat 61 Atiprimod 61 phase IIb 61 BiTE antibody 61 potent inhibitor 61 TLR7 61 Rasilez 61 Androxal 61 pharmacokinetic profile 61 telbivudine 61 APF# 61 Welchol 61 immunomodulatory 61 IDX# 61 Phase III clinical 60 mixed dyslipidemia 60 DG# [001] 60 perifosine 60 ambrisentan 60 dasatinib 60 XL# [003] 60 Preclinical studies 60 Phase IIb 60 tivozanib 60 antiviral activity 60 dapagliflozin 60 blinatumomab 60 JANUVIA 60 Phase IIa 60 MGCD# [002] 60 antitumor activity 60 kinase inhibitor 60 INGN 60 ADX# 60 hematologic malignancies

Back to home page